ReviewCureus2026
The Bidirectional Relationship Between Rheumatoid Arthritis and Periodontitis: Current Evidence and Clinical Implications.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) and periodontitis are chronic inflammatory diseases that share several pathogenic, immunological, and environmental characteristics. Increasing evidence suggests that these conditions are linked through a potentially bidirectional relationship in which chronic periodontal inflammation may contribute to the initiation and progression of RA, whereas RA may predispose individuals to periodontal tissue destruction through systemic inflammation, immune dysregulation, and impaired oral hygiene. This narrative review summarizes the current understanding of the epidemiological association between RA and periodontitis and discusses the shared inflammatory pathways, including cytokine dysregulation, osteoclast activation, and altered host immune responses, that underlie both diseases. Particular emphasis is placed on the reciprocal influence of periodontitis on RA activity and the impact of RA on periodontal disease. Available evidence indicates that periodontal infection may amplify the systemic inflammatory burden and autoimmune responses, whereas chronic inflammatory changes associated with RA can accelerate periodontal tissue breakdown and increase the risk of disease progression. Emerging clinical evidence also suggests that periodontal therapy may serve as a valuable adjunct to conventional RA management by reducing the systemic inflammatory burden and improving disease activity, although definitive causal relationships have not yet been established. Periodontal therapy may have beneficial effects on systemic inflammatory markers and selected measures of RA activity, although the clinical significance and consistency of these effects remain uncertain. Recognition of this bidirectional association highlights the importance of interdisciplinary collaboration between dental professionals and rheumatologists to facilitate early diagnosis, comprehensive patient assessment, and development of integrated treatment strategies. Future longitudinal and interventional studies are warranted to clarify the causal mechanisms linking these conditions and determine whether improved periodontal health can contribute to better long-term outcomes in patients with RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.